For episode 26 of 17 Minutes of Science, we are joined by Dr. Jeremy Levin. Dr Levin is the current chairman and CEO of Ovid Therapeutics, Inc., a company working to bring impactful treatments to patients who have rare neurological conditions. Dr. Levin is also the chairman of the Biotechnology Innovation Organization (BIO) and was named by FierceBiotech in 2018 as one fo the most influential people in biopharma. Additionally, Dr. Levin recently published a book, Biotechnology in the Time of COVID.

Dr. Levin joins us on 17 Minutes of Science to discuss his recent book and to dig a bit deeper into the impact of the current coronavirus pandemic on biotech, biopharma, and clinical trials.